Close Menu

Microfluidic Systems

Pursuing what it sees as a burgeoning interest from investors and potential partners in increasingly smaller molecular diagnostic platforms, PositiveID has begun developing a battery-operated, handheld version of Dragonfly, its benchtop, cassette-based molecular testing system, t

Roche wins multiple US patents; Life Tech, Stanford, Medical Diagnostic Labs, PositiveID, and STMicroelectronics also awarded US patents.

The IP is assigned to Microfluidic Systems, which applied for the patent in September 2005 and is in the process of being acquired by PositiveID in a deal worth up to $8.2 million.

The deal, worth as much as $8.2 million, is expected to enable the medical-tech firm to expand into the biodefense and clinical diagnostics markets via MFSI's multiplexed molecular assays and automated, PCR-based sample-to-answer technology.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.